mci 9038 has been researched along with Coronary Restenosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirohata, A; Kataoka, K; Kimura, T; Kozuma, K; Morino, Y; Tanabe, K; Tobaru, T; Yasuda, S | 1 |
Butterworth, J; Cannon, MA; Hyland, JM; Riley, RD | 1 |
Daikoku, S; Goto, Y; Itoh, A; Itoh, T; Miyazaki, S; Morii, I; Nonogi, H | 1 |
Fujii, M; Hirahara, T; Ikeda, N; Kubo, N; Matsushima, K; Ohmura, N; Saito, M; Yasu, T | 1 |
2 trial(s) available for mci 9038 and Coronary Restenosis
Article | Year |
---|---|
Local delivery of argatroban for the prevention of restenosis after coronary balloon angioplasty: a prospective randomized pilot study.
Topics: Aged; Angioplasty, Balloon; Arginine; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Risk Factors; Sulfonamides; Time Factors | 2004 |
[Prospective randomized study of argatroban versus heparin anticoagulation therapy after percutaneous coronary intervention for acute myocardial infarction].
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Coronary Restenosis; Heparin; Humans; Myocardial Infarction; Pipecolic Acids; Prospective Studies; Sulfonamides | 2004 |
2 other study(ies) available for mci 9038 and Coronary Restenosis
Article | Year |
---|---|
Biodegradable polymer-based, argatroban-eluting, cobalt-chromium stent (JF-04) for treatment of native coronary lesions: final results of the first-in-man study and lessons learned.
Topics: Absorbable Implants; Adult; Aged; Aged, 80 and over; Arginine; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pipecolic Acids; Sulfonamides; Treatment Outcome | 2016 |
Failure of argatroban anticoagulation during off-pump coronary artery bypass surgery.
Topics: Aged; Angina, Unstable; Antibodies; Anticoagulants; Arginine; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Restenosis; Dose-Response Relationship, Drug; Graft Occlusion, Vascular; Heparin; Humans; Male; Myocardial Revascularization; Partial Thromboplastin Time; Pipecolic Acids; Reoperation; Stents; Sulfonamides; Treatment Failure | 2004 |